Immunofluorescence-detected infiltration of CD4 +FOXP3 + regulatory T cells is relevant to the prognosis of patients with endometrial cancer

International Journal of Gynecological Cancer

Volumn 21, Issue 9, 2011, Pages 1628-1634

  Yamagami, Wataru ^a   Susumu, Nobuyuki ^a   Tanaka, Hideo ^a   Hirasawa, Akira ^a   Banno, Kouji ^a   Suzuki, Nao ^b   Tsuda, Hiroshi ^a   Tsukazaki, Katsumi ^a   Aoki, Daisuke ^a  

^a KEIO UNIVERSITY   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytotoxic T lymphocytes; Endometrial cancer; FOXP3; Regulatory T cells; Tumor immunity

Indexed keywords

CD8 ANTIGEN; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; REGULATORY T LYMPHOCYTE; UTERUS; AGED; CELL DIFFERENTIATION; ENDOMETRIUM TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; AGED, 80 AND OVER; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; ENDOMETRIAL NEOPLASMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; PROGNOSIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84857404712     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31822c271f     Document Type: Article

References (24)

1. Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer. 2005;5:263-274. (Pubitemid 40488632)
2. Gallimore A, Godkin A. Regulatory T cells and tumour immunity - observations in mice and men. Immunology. 2008;123:157-163.
3. Leffers N, Gooden MJ, de Jong RA, et al. Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Cancer Immunol Immunother. 2009;58:449-459.
4. + tumor-infiltrating lymphocytes in ovarian carcinoma. Gynecol Oncol. 2008;108:415-420.
5. + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 1998;58:3491-3494.
6. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-1061. (Pubitemid 36222930)
7. +regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6:345-352.
8. Yamaguchi T, Sakaguchi S. Regulatory T cells in immune surveillance and treatment of cancer. Semin Cancer Biol. 2006;16:115-123. (Pubitemid 43172060)
9. Wolf D, Wolf AM, Rumpold H, et al. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res. 2005;11:8326-8331. (Pubitemid 41746944)
10. +/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A. 2005;102:18538-18543.
11. Molling JW, de Gruijl TD, Glim J, et al. CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia. Int J Cancer. 2007;121:1749-1755. (Pubitemid 47417293)
12. +regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res. 2007;13:902-911.
13. +T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol. 2009;27:186-192.
14. Merlo A, Casalini P, Carcangiu ML et al. FOXP3 expression and overall survival in breast cancer. J Clin Oncol. 2009;27:1746-1752.
15. + T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin Cancer Res. 2007; 13:4345-4354
16. Lurain JR. Uterine cancer. Berek JS, ed. Novak's Gynecology. 14th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:1348-1382.
17. International Federation of Gynecology and Obstetrics. Annual report on the results of treatment in gynecologic cancer. Int J Gynecol Obstet. 1989;28:189-190.
18. Nishiya M, Sakuragi N, Hareyama H, et al. Cox multivariate regression models for estimating prognosis of patients with endometrioid adenocarcinoma of the uterine corpus who underwent thorough surgical staging. Int J Cancer. 1998;79:521-525. (Pubitemid 28445276)
19. de Jong RA, Leffers N, Boezen HM, et al. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer. Gynecol Oncol. 2009;114:105-110.
20. + lymphocytes correlates with intratumoral angiogenesis in endometrial cancer. Gynecol Oncol. 2008;110:216-221.
21. + effector populations in patients with human endometrial carcinoma. Cancer. 2010;116:5777-5788.
22. Zuo T,Wang L, Morrison C, et al. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell. 2007;129:1275-1286. (Pubitemid 46970708)
23. Hinz S, Pagerols-Raluy L, Oberg HH, et al. Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res. 2007;67:8344-8350. (Pubitemid 47395173)
24. Wang L, Liu R, Li W, et al. Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell. 2009;16:336-346.